Thus, increased expression and/or nuclear accumulation of YAP drives tumor initiation, progression, metastasis, drug resistance, immune evasion, and stemness, underscoring YAP as a potent oncogene and therapeutic target in cancer. This evidence concerns the gene YAP1 and neoplasm.